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Abstract
Background: Peroneal nerve is susceptible to injuries due to its anatomical course. Excessive
weight loss, which reduces the fatty cushion protecting the nerve, is considered a common
underlying cause of peroneal palsy. Other predisposing factors, such as prolonged postures,
traumas of the region or concomitant pathologies (for example diabetes mellitus) contribute to the
nerve damage. This study aims to reveal the multiple predisposing factors of peroneal nerve
mononeuropathy after substantial weight loss that coexist in psychiatric patients and to make
suggestions on their management.
Methods:  Nine psychiatric inpatients, major depressive or schizophrenic, with foot drop
underwent a complete clinical neurological and neurophysiological examination. All had excessive
weight loss, which was completed in a short period of time and had not resulted from a well-
balanced low-calorie diet, but was due to their psychiatric illness. Data regarding predisposing
factors to peroneal nerve mononeuropathy were gathered, such as habitual leg crossing, squatting
or other prolonged postures.
Results:  The clinical examination and the neurophysiological evaluation in all patients were
indicative of a focal lesion of the peroneal nerve at the fibular head.
Conclusion:  Patients with major depressive and schizophrenic disorders gather multiple
predisposing factors to peroneal palsy, adequate to classify them at a high risk group. The better
focus of the attendant medical and nursing staff on this condition, the early clinical and
neurophysiologic evaluation and surgical interventions may enable an improved management and
prognosis of these patients.
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Background
It is well established that the peroneal nerve is susceptible
to injuries due to its anatomical course. The common per-
oneal nerve (PN) originates as one of the two terminal
divisions of the sciatic nerve at the apex of the popliteal
fossa. At the level of the fibular head it divides into its ter-
minal branches (deep and superficial PN). Due to its
superficial anatomical course around the fibular neck,
where it is covered only by skin, subcutaneous tissue and
a fat pad, the nerve is susceptible to damage due to pres-
sure against the bone [1].
The main presenting symptom in lesions of PN is foot-
drop, due to paresis of the dorsiflexor muscles of the foot
and toes. When severe, it can be noticed as a change in the
patient's gait (steppage gait) (i.e. the patient raises the foot
higher, when swinging it forward, to avoid striking the
toes on the ground). Sensory deficits, such as decreased
touch and pin-prick sensation over the anterolateral leg
and dorsum of the foot, are more common in such cases,
rather than pain or paresthesias [1].
Excessive weight loss, which reduces the fatty cushion pro-
tecting the nerve, is considered one of the most frequent,
if not the most common underlying cause of peroneal
palsy [1,2]. Endocrine and metabolic disorders (i.e. diabe-
tes mellitus, alcoholism, thyrotoxicosis or vitamin B
depletion), trauma [3], perioperative damage [1,3],
venous thrombosis [4], habitual leg-crossing and pro-
longed squatting have also been identified as predispos-
ing factors [3]. The association between weight loss, leg
crossing and the development of pressure paralysis of the
peroneal nerve was first described in 1929 by Woltman
H.W. [5].
Isolated peroneal palsy has been previously observed
exclusively in patients suffering from depression [6-8]. In
this study, we present nine psychiatric inpatients, suffer-
ing from major depressive or schizophrenic disorders who
developed peroneal nerve mononeuropathy after sub-
stantial weight loss. This group of patients was studied
clinically and neurophysiologically in an attempt to
present the multiple predisposing factors that coexist in
this category of patients and to make suggestions regard-
ing their management.
Methods
Nine Caucasian psychiatric inpatients (eight male) were
referred to our laboratory from 1992 until 2008, because
of footdrop. In one patient (case 9), footdrop was the sec-
ondary reference indication, since it occurred seven years
prior to examination. The mean age of patients was 46.8
years (range 29–73 years). All had substantial weight loss,
more than 10% of their initial body weight (in five
patients the loss was greater than 20%). The weight loss
occurred in a short period of time (weeks). Five patients
suffered from a major depressive episode in the context of
a major depressive disorder and four from a schizophrenic
disorder, according to the DSM-IV diagnostic criteria [9].
This retrospective study was conducted according to the
principles outlined in the Declaration of Helsinki.
Initially, the following clinical data were acquired: symp-
toms and duration, type of onset, psychiatric history,
duration of illness, number of previous hospitalizations,
medications, weight loss (in kilograms, percentage of ini-
tial weight and rate of loss), other predisposing factors
(e.g. inactivity, habitual leg-crossing, squatting, pro-
longed postures, trauma), and concomitant pathology
(diabetes, metabolic or toxic diseases, alcohol abuse, vita-
min deficiency). Data on the concomitant pathology were
additionally checked by a set of appropriate laboratory
tests (Table 1).
All patients underwent a complete clinical, neurological
examination. Especially, the bulk and contour of tibi-
ofibular muscles were examined and the muscle strength
of posterior thigh and tibiofibular muscles was graded
according to the British Medical Research Scale. Light
touch and pinprick sensation were tested in the cutaneous
distribution of the lateral cutaneous nerve of the calf and
in the superficial and deep sensory branches of the com-
mon peroneal nerve. Polyneuropathy was assessed with
NSS (Neurological Symptom Score) [10].
The neurophysiological examination was conducted
using standard methods in a warm room, with a Nihon
Kohden Neuropack Σ. Motor and sensory nerve conduc-
tion studies of peripheral nerves in the lower (deep pero-
neal, tibial, superficial peroneal and sural nerve) and
upper limbs (median and ulnar nerve) as well as concen-
tric needle electromyography of muscles in the lower
limbs were performed. In particular, the motor conduc-
tion velocity of the peroneal nerve at the ankle, below the
fibular head and at the lateral popliteal fossa and the sen-
sory conduction velocities of the superficial peroneal and
the sural nerve were calculated. The electromyographic
evaluation of the tibialis anterior, the extensor digitorum
brevis, the peroneus longus and the gastrocnemius was
performed using a disposable concentric needle electrode
(Medtronic DCN 50), at rest and during voluntary action.
Results
The clinical examination and the neurophysiological eval-
uation in all patients were indicative of isolated damage of
the peroneal nerve. None of the patients had abnormali-
ties in the distribution of other peripheral nerve of the
limb, indication of lumbosacral radiculopathy, plexopa-
thy, or sciatic neuropathy. Moreover, none met the criteria
for a generalized peripheral neuropathy. Six patients didJ
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Table 1: Clinical data
Patient Sex Age (years) Psychiatric 
illness
Duration of 
psychiatric 
illness/number 
of previous 
hospitalizations
Weight (in kg)/
loss (in kg)/% 
initial body weight
Onset of 
symptoms (in 
days prior to 
examination)
Main presenting 
symptom
Medications Concomitant 
pathology
1 Male 57 Major depressive 
episode in the 
context of a major 
depressive 
disorder
7 months/2 
hospitalizations.
71/12/16.9% 20 Footdrop R, 
weakness of 
dorsiflexor 
muscles R.
maprotiline 
amitriptyline, 
diazepam, 
levomepromazine
none
2 Male 43 Schizophrenic 
disorder
23 years/none 70/20/22.2% 45 Footdrop L olanzapine, 
haloperidol, 
biperiden
well controlled 
diabetes
3 Male 29 Schizophrenic 
disorder
6 years/2 
hospitalizations
68/20/22.7% 18 Weakness R trifluoperazine, 
amitriptyline 
biperiden.
none
4 Male 62 Major depressive 
episode in the 
context of a major 
depressive 
disorder
1 year/1 
hospitalization
67/18/21.2% 55 Weakness of 
dorsiflexor 
muscles L
amitriptyline, 
clomipramine, 
chlorpromazine, 
quazepam.
none
5 Male 36 Major depressive 
episode in the 
context of a major 
depressive 
disorder
4 years/none 92/23/20% 20 Weakness of 
dorsiflexor 
muscles L > R
clomipramine, 
sertraline
none
6 Female 73 Major depressive 
episode in the 
context of a major 
depressive 
disorder
2 years/1 
hospitalization
66/10/13.2% 45 Weakness of 
dorsiflexor 
muscles R
paroxetine, 
mirtazapine
none
7 Male 38 Schizophrenic 
disorder
2 years/2 
hospitalizations
70/13/15.6% 60 Footdrop L, 
weakness of 
dorsiflexor 
muscles L.
aripiprazole, 
olanzapine
none
8 Male 41 Schizophrenic 
disorder
21 years/3 
hospitalizations
118/35/22.9% 7 years (2520) sensory deficits R risperidone, 
clomipramine, 
bromazepam
well controlled 
diabetes
9 Male 43 Major depressive 
episode in the 
context of a major 
depressive 
disorder
20 years/1 
hospitalization
106/12/11.3% 90 Footdrop R, 
weakness of 
dorsiflexor 
muscles R
venlafaxine 
hydrochloride, 
levomepromazine, 
quetiapine fumarate, 
escitalopram, 
clorazepate 
dipotassium, 
lamotrigine
noneJournal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:24 http://www.jbppni.com/content/3/1/24
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not have concomitant pathology nor did they receive
medications known to cause peripheral neuropathy. Two
patients suffered from a well-controlled type 2 diabetes
mellitus, according to laboratory findings.
The electrophysiological studies of the deep peroneal
nerve showed a partial motor nerve conduction block,
according to the AAEM criteria [11], at the fibular head in
seven patients (cases 1–5, 7, 9), and slowing of the con-
duction velocity in the popliteal fossa – fibular head seg-
ment in six (cases 2–5, 9). In cases 6 and 8, the findings
were indicative of axonal damage. The amplitude of the
sensory potential of the superficial peroneal nerve was
abnormally low in five patients, while sensory conduction
velocity was within normal limits in all but one patient
(case 9). (Table 2)
The electromyographic evaluation in nine patients
showed a reduction in the number of recruited motor
units of the muscles innervated by the peroneal nerve. In
six patients (cases 1, 2, 3, 5, 7, 9) there were also signs of
ongoing denervation (fibrillation potentials and/or posi-
tive sharp waves). In case 9, the data were indicative of
reinnervation process (no spontaneous activity, polypha-
sic, but stable motor unit action potentials).
The above are suggestive of a focal lesion of the peroneal
nerve at fibular head, which consisted in demyelination
with conduction block in seven patients and concomitant
axonal loss in five. The lesion was predominantly axonal
in patients 6 and 8 and there were findings of residual
axonal damage in patient 9.
Discussion
Although, peroneal nerve palsy is a common mononeu-
ropathy (approximately 15% of all mononeuropathies in
adults) [2], few reports have previously been published
regarding patients with psychiatric history. Moreover, all
of these studies regard, exclusively, suffers from depres-
sion. Our group of patients comprises both sufferers of
depression and schizophrenia. All had excessive weight
loss which, noticeably, was completed in a short period of
time and did not result from a well-balanced low-calorie
diet, but was due to their psychiatric illness. Appetite loss
is common in major depression. Delusional beliefs of
worthlessness, guilt and deserved punishment leading to
food abstinence are also common. Delusional beliefs of
persecution (e.g. food poisoning) or of religious content
with fasting are not infrequent in schizophrenic patients.
It is plausible that our patients were deficient in certain
vitamins or other nutrients necessary for nerve function,
though no relevant data were gathered. Weight loss is
highlighted as an important factor in this study, since sev-
eral components of the patients' psychopharmacological
regimen have as a side-effect weight gain (e.g., amitrip-
tiline, chlomipramine, olanzapine) [12]. The patients
tended to take prolonged postures, such as leg-crossing or
squatting, or displayed immobility. The above can be
observed commonly both in patients with major depres-
sion and chronic schizophrenia.
The neurophysiological examination of our patients was
suggestive of an entrapment neuropathy of the peroneal
nerve at the fibular head. The conduction studies and elec-
tromyography showed that the underlying pathology was
focal demyelination presenting as conduction block, with
or without significant reduction of conduction velocity
Table 2: Motor and Sensory (antidromic method) nerve conduction study of the peroneal nerve, using superficial recording electrodes
Patient MCV1 Pop-
liteal Fossa- 
fibular head 
(m/sec)
MCV Below 
fibular head- 
ankle (m/sec)
CMAP2 
Amplitude 
Popliteal 
Fossa (mV)
CMAP 
Amplitude 
Ankle (mV)
Distal CMAP 
Latency (ms)
SCV3 (m/sec) SNAP4 
Amplitude 
(μV)
Distal SNAP 
latency (ms)
LRLRLRLRLR L R L RLR
1 48 46 48 46 4.0 1.0 4.0 3.0 4.0 4.2 45 44 7 5 2.9 3.1
2 32 48 47 49 0.5 4.3 2.5 5.0 3.6 4.0 51 52 4 16 2.9 2.5
3 46 35 45 37 6 0.5 7.0 6.0 4.7 4.7 50 45 30 15 2.7 3
4 32 49 50 52 0.2 4 2.5 3.0 4.1 4.8 50 50 6 6 2.4 2.5
5 14 25 39 42 0.5 0.5 4.0 5.0 4.5 4.0 40 40 4 5 3.7 3.1
6 54 53 53 51 7.0 2.0 7.0 2.4 3.5 4.0 51 50 14 12 2.8 2.6
7 46 46 46 44 0.8 6.0 2.0 6.0 4.0 4.0 46 50 5 11 2.8 2.6
8 53 45 50 47 6.0 2.5 6.0 2.3 3.9 4.5 55 57 9 8 2.4 2.6
9 50 35 48 46 5 1 6 5 4 4.2 50 44 9 4 2.8 3.6
1 Lower normal limit 42 m/sec. The lower normal limit of MCV and SCV indicative of axonal damage is 29.5 m/s
2 Lower normal limit 3 mV
3 Lower normal limit 42 m/sec
4 Lower normal limit 5 μVJournal of Brachial Plexus and Peripheral Nerve Injury 2008, 3:24 http://www.jbppni.com/content/3/1/24
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and a varying amount of axonal damage. In case 9, with a
seven year history of peroneal nerve palsy, the findings
were indicative of residual axonal damage. The involve-
ment of a considerable proportion of axons is associated
with a less favorable outcome and a prolongation of the
rehabilitation time.
The study of this group of patients highlights matters
regarding their management. (Table 3). Depressive and
schizophrenic patients gather multiple predisposing fac-
tors to peroneal neuropathy. Weight loss in combination
with psychomotor retardation, prolonged postures and
inactivity are such factors placing these patients at a high
risk group for peroneal palsy. This has already been sug-
gested for patients with depression [7] but not, as yet, for
schizophrenic patients.
In order to provide the best possible management, several
obstacles to communication should be overcome. These
patients might not complain of their symptoms or, con-
versely, might exaggerate their complaints, making them
less believable. Moreover, questions about whether the
patients' symptoms are genuine or delusional, or hypo-
chondrial, can only be answered by a thorough clinical
and, eventually an electrophysiological examination. In
addition to the above, an MRI of the lower leg region
should be considered, in order to exclude other lesions
causing peroneal nerve damage (e.g. ganglion cyst, aneu-
rysm, synovial cyst or osteochondroma) [13].
Although most peroneal palsies due to demyelination
recover spontaneously after removal of the predisposing
factors, there are a number of cases, exemplified by patient
9, where concomitant axonal damage can lead to pro-
longed or permanent paralysis and atrophy and thus need
to be evaluated for an eventual surgical intervention. The
neurophysiological examination can establish the exist-
ence and degree of axonal involvement, providing a basic
indication for interventional treatment. The time course
of the repair interventions is an important factor. Patients
should be referred as soon as possible to a qualified cen-
tre, where restoration techniques of the nerve function can
be performed. The surgical repair is the usual manage-
ment, at least initially. Surgical exploration, neurolysis,
partial fibulectomy and graft repairs (from the sural or tib-
ial nerve) are commonly performed [14,15]. If nerve sur-
gery fails to reconstitute a useful foot lift, patients need to
be evaluated for their suitability to undergo tendon trans-
fer or other reconstructive procedures. In about 3 weeks
after the surgery, the patients can begin physiotherapy. It
is advisable that a follow-up with clinical and neurophys-
iological examination at 6 months should be pro-
grammed, in order to reveal the degree of function
recovery.
As far as prevention is concerned, the role of the attendant
medical and nursing staff is important. A well-balanced
and nutritious dietary plan should be established for these
patients, who should be also instructed to avoid habitual,
prolonged postures during which pressure is exerted on
the nerve.
Conclusion
The findings of this study suggest that more attention
should be given to identify early signs of peroneal neurop-
athy in psychiatric inpatients with major depressive or
schizophrenic disorders. Prompt neurological and neuro-
physiological examination can reveal the extent and the
severity of the damage and to enable early surgical inter-
Table 3: Suggestions on patients' management
First Evaluation After the establishment of the diagnosis 
of peroneal nerve mononeuropathy
Preventive means
Detailed history; overcome obstacles in 
communication (onset of symptoms, weight 
loss, tendency to retain prolonged postures, 
e.g. squatting, legs crossed, is the patient bed-
bound)
If exclusive or predominant demyelination:
Conservative treatment 
(appropriate diet, mobilization physiotherapy)
Information of medical and nursing staff in 
psychiatric units
Complete clinical neurological examination If predominantly axonal lesion and/or anatomical 
causes:
Reference to qualifying centre for surgical 
repair (e.g. neurolysis)
Physiotherapy 
(approximately 3 weeks after the surgery)
Clinical outcome evaluation-follow up after 6 
months
If not satisfied with the clinical outcome, 
consideration for additional surgical 
management (e.g. tendon transfer)
Patients' weight monitoring, establishment of 
well-balanced, nutritious dietary plan
Reference for neurophysiological and 
electromyographic examination
Mobilization of patients and avoidance of 
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ventions, contributing to the better management and
long-term prognosis for these patients.
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